Drug or treatment
Nilotinib clinical trials
As of November 12, 2026, Find a Trial lists 4 clinical trials of Nilotinib that are recruiting, at sites in 2 countries (most in United States (3), Spain (1)). By phase: Phase 2 (3), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Potential of asciminib in early chronic‑phase CML | Phase 2 | Barcelona and 10 other locations | Recruiting | May 10, 2024 |
| Combining nilotinib with other drugs for treating metastatic melanoma | Phase 1 | Iowa City, Iowa and 3 other locations | Recruiting | May 26, 2021 |
| Testing nilotinib and paclitaxel for rare cancers | Phase 2 | Bethesda, Maryland | Recruiting | Jun 29, 2020 |
| Using ponatinib for patients with chronic myeloid leukemia who didn't respond to other treatments | Phase 2 | Houston, Texas | Recruiting | Dec 11, 2012 |
All recruiting trials (4)
-
Potential of asciminib in early chronic‑phase CML
This trial will see if asciminib alone, or asciminib plus nilotinib, helps adults newly diagnosed with chronic‑phase, BCR‑ABL–positive CML reach deep molecular responses and remain off treatment.
-
Combining nilotinib with other drugs for treating metastatic melanoma
This study is testing if adding nilotinib to existing treatments can help people with advanced melanoma that has a specific genetic mutation feel better and tolerate the drugs well.
-
Testing nilotinib and paclitaxel for rare cancers
This study is testing a new combination of two drugs, nilotinib and paclitaxel, to see if it can help adults with rare solid tumors that haven't responded to other treatments.
-
Using ponatinib for patients with chronic myeloid leukemia who didn't respond to other treatments
This study is testing if ponatinib can help people with chronic myeloid leukemia who didn't respond to other treatments feel better and improve their health.
Quick answers
How many clinical trials of Nilotinib are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (3 trials), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.